Back to Agenda
[Special Lecture] Dynamic ASEAN Pharmaceutical Environment with Challenges and Opportunities
Session Chair(s)
Shun Jin, MBA
Head – BD & RA, PharmaGend Global Medical Services Pte Ltd, Singapore
In ASEAN, the regulatory environment is changing very fast. The dynamic regulatory requirement brings challenges to the industry. In 2017, the pharmaceutical law in Vietnam has been updated and implemented. Industry is trying to digest the new requirements in this regulation and the speaker form DAV will give the explanation on the key updates in the new regulation. In addition, there will be another presentation from industry perspective. The session explores the ASEAN pharmaceutical environment from the onset of the ASEAN Consultative Committee for Standards and Quality (ACCSQ) Pharmaceutical Product Working Group (PPWG), Technical Working Groups (TWG), Implementation Working Group (IWG) and ASEAN guidelines. Providing insights on the latest development in PPWG, updates and future area of guidance discussion. Discussing the challenges faced by industry members and opportunities for industry in creating favourable regulatory environment in expediting approval of innovative medicines for patients in ASEAN.
Speaker(s)
Mai Huong Thi Nguyen
Officer, Drug Registration Division, Drug Administration of Vietnam, Vietnam
Regulatory Environment in Vietnam
Kum Cheun Wong, PharmD
Head Asia Pacific Regulatory & Development Policy, Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
ASEAN Pharmaceutical Environment: Industry Perspective on Challenges, Opportunities and Prospects of Partnerships
Have an account?